If youre curious whether GLP-1 therapy is appropriate for your weight management goals or overall health plan, wed be happy to discuss your options during a consultation
While semaglutide itself does not cause significant hepatotoxicity, patients with pre-existing liver disease, those who consume 3 or more alcoholic drinks every day, or individuals taking other potentially hepatotoxic medications should consult their healthcare provider before regular acetaminophen use
Use of GLP-1 Drugs to Treat Overweight or Obesity Increased 587 Percent from 2019 to 2024, According to New FAIR Health Study News provided by FAIR Health May 27, 2025, 08:11 ET GLP-1 Prescriptions Increased 364 Percent for All Adults, and 588 Percent for Younger Adults Bariatric Surgeries Declined 42 Percent NEW YORK, May 27, 2025 /PRNewswire/ -- Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to newly released FAIR Health data
trials ran to 68 weeks with continued, progressive weight loss [2]
El llamado es a tener cuidado, informarse y no minimizar el riesgo, sentencia
